Kazakhstan intends to localize 29 pharmaceutical production facilitiesLong-term contracts and agreements have been signed with Roche, Pfizer, AstraZeneca, Philips, GE HealthCare

Vice Minister of Health Zhandos Burkitbaev at a meeting government said that by the end of 2023 year, the volume of the pharmaceutical market in Kazakhstan amounted to 949.8 billion tenge, of which domestic production – 144.3 billion tenge. Share of domestic production in the domestic market amounted to 14.4%, reports the correspondent of the business information center Kapital.kz from link to the press service of the department. “Of these, in the procurement system of the Single Distributor, the turnover pharmaceutical products amounted to 436.9 billion tenge, of which domestic production – 137.5 billion tenge or 31.5%,” he said. The Vice Minister recalled that the President had set the Ministry of Health the task of increasing the share of domestically produced drugs to 50% on the domestic market by 2029. “There are 193 domestic producers in Kazakhstan, of which the top 10 were determined: by medicines; medical products and medical equipment, they make up the largest share in domestic production. Currently, the possibility of reloading them with taking into account the existing potential of the production capacities of these enterprises,” – explained the vice minister. To develop the industry, work is underway with foreign investors to localize 29 new projects in Kazakhstan production of medicines and medical products. “Long-term agreements have been signed with such companies as: Roche – drugs for the treatment of oncological diseases, Pfizer – 20-valent pneumococcal vaccine, an investment project is being developed with AstraZeneca – drugs for the treatment of oncological, autoimmune and cardiovascular diseases. Also concluded agreement of intent between the ministry and Philips – portable Ultrasound equipment, GE HealthCare – high-tech diagnostic medical equipment,” said Zhandos Burkitbaev. The Vice Minister added that the digitization of the public procurement process in the regions, carried out by medical organizations, will allow a projected increase in the share of domestic production up to 20%. Currently, the share of government procurement domestic products account for 14.4%. Zhandos Burkitbaev proposed: – The Center for Electronic Finance of the Ministry of Finance should accelerate the completion of digitalization of procurement procedures; – in regional development plans, to consolidate akimats indicator for priority purchase of domestic pharmaceutical products; – bring National registration dossiers into compliance with the requirements of the EAEU rules, ensure promotion of pharmaceutical products of domestic manufacturers in the EAEU countries. https://kapital.kz/economic/126193/v-kazakhstane-namereny-lokalizovat-29-farmproizvodstv.html